CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hepatitis delta: phase 3 trial launches
Disease control Recruiting nowThis phase 3 trial compares a new drug, brelovitug, to an existing treatment (bulevirtide) for chronic hepatitis delta, a serious liver infection. About 172 adults with the infection will receive either drug to see which better controls the virus and normalizes liver enzymes. The…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for hepatitis d: libevitug enters final testing phase
Disease control Recruiting nowThis Phase 3 trial is testing a new drug called libevitug in 160 people with chronic hepatitis D, a serious liver infection. The goal is to see if libevitug can lower the virus in the blood and improve liver health. Participants receive the drug by IV infusion, and the study comp…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE3 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New antibody could tame dual hepatitis b and d infection
Disease control Recruiting nowThis early-stage trial tests a lab-made antibody (HepB mAb19) in 15 people with chronic hepatitis D, a serious liver infection that requires hepatitis B to survive. The goal is to see if the antibody is safe and can lower virus levels, potentially reducing the risk of liver damag…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE1 • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC